The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.
The Million Hearts initiative launched in 2012 set a lofty goal of preventing 1 million cardiovascular deaths in 5 years, but did not quite achieve that target. According to the program’s executive director, Janet Wright, MD, FACC, Million Hearts will continue to make progress in part due to the solid foundations it has formed in the initial stage.
Transcript (slightly modified)
What are the goals of the Million Hearts initiative?
The aim of Million Hearts 2022 is exactly the aim of Million Hearts 1.0, and that is to prevent a million cardiovascular events over a 5-year time frame. We made progress in our first 5 years, but I don’t think we’re going to get to a million. The projected numbers indicate we’ll probably fall short of that.
But we’ve amassed extraordinary partnerships and instituted policies. We’ve seen programs and pilots be launched during the first 5 years that will extend well beyond and will continue to make improvements in cardiovascular health and cardiovascular care.
What did your team learn from the obstacles the initiative has encountered in the first stage?
What we learned in 5 years of working is that change is hard, and it takes time. We’re frustrated by the slow pace of that change, but we did see progress. Over the 5 years of 2012 to 2016, we saw blood pressure control improve by about 1% per year. In order to deliver a million events, our model showed that we needed improvement at 5% per year.
The good news is that we saw, we met, and we learned from high performers in blood pressure control around the country over that 5 years’ time, so we know that high performance is possible, and many of those lessons turned into success stories that are available on our website.
With cholesterol, we saw an improvement a little bit greater, and we’re going to get close to the population level target that we set, but we’re not going to get all the way there. We did see a target reached in terms of smoking cessation, and it’s due to collective efforts around the country. In fact, 7 million people had stopped smoking over the period of Million Hearts.
We’ve seen a little bit of an improvement in aspirin, but we didn’t make any headway at all in sodium reduction. All of those factors needed to occur together in order to prevent a million.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More